DOI : 10.1055/s-00000041

Neuropediatrics

Ausgabe S 02 · Volume 49 · Oktober 2018 DOI: 10.1055/s-008-41768


Abstracts of the 44th Annual Meeting of the Society for Neuropediatrics
Berlin, 30.10 – 03.11.2018

Chair: Prof. Dr. Volker Mall, Department of Pediatrics, University Hospital, Technical University Munich
Abstracts (HTML) Autorenliste
IP110
Devinsky, Orrin; Nabbout, Rima; Miller, Ian; Laux, Linda; Żołnowska, Marta; Wright, Stephen; Roberts, Claire: IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5)
IP112
Gil-Nagel, Antonio; Privitera, Michael; Bhathal, Hari; Wong, Matthew H.; Cross, J. Helen; Wirrell, Elaine C; Sommerville, Kenneth; Roberts, Claire: IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials
IP467
Guyot, P.; Kalyvas, C.; Weijers, L; Karabis, A.; Danchenko, N.: IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis
IP1184
Polster, Tilman; Lagae, Lieven; Sullivan, Joseph; Brandl, Ulrich; Herting, Arne; Jacobs, Julia; Kluger, Gerhard; Mayer, Thomas; Panzer, Axel; Pringsheim, Milka; Stephani, Ulrich; Wolff, Markus; Farfel, Gail; Galer, Bradley S.; Gammaitoni, Arnold; Lock, Michael; Mistry, Arun; Morrison, Glenn; Ceulemans, Berten: IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial